Literature DB >> 23885013

Evidence for the regulatory role of lipocalin 2 in high-fat diet-induced adipose tissue remodeling in male mice.

Hong Guo1, Merlijn Bazuine, Daozhong Jin, Merry M Huang, Samuel W Cushman, Xiaoli Chen.   

Abstract

Lipocalin 2 (Lcn2) has previously been characterized as an adipokine/cytokine playing a role in glucose and lipid homeostasis. In this study, we investigate the role of Lcn2 in adipose tissue remodeling during high-fat diet (HFD)-induced obesity. We find that Lcn2 protein is highly abundant selectively in inguinal adipose tissue. During 16 weeks of HFD feeding, the inguinal fat depot expanded continuously, whereas the expansion of the epididymal fat depot was reduced in both wild-type (WT) and Lcn2(-/-) mice. Interestingly, the depot-specific effect of HFD on fat mass was exacerbated and appeared more pronounced and faster in Lcn2(-/-) mice than in WT mice. In Lcn2(-/-) mice, adipocyte hypertrophy in both inguinal and epididymal adipose tissue was more profoundly induced by age and HFD when compared with WT mice. The expression of peroxisome proliferator-activated receptor-γ protein was significantly down-regulated, whereas the gene expression of extracellular matrix proteins was up-regulated selectively in epididymal adipocytes of Lcn2(-/-) mice. Consistent with these observations, collagen deposition was selectively higher in the epididymal, but not in the inguinal adipose depot of Lcn2(-/-) mice. Administration of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone (Rosi) restored adipogenic gene expression. However, Lcn2 deficiency did not alter the responsiveness of adipose tissue to Rosi effects on the extracellular matrix expression. Rosi treatment led to the further enlargement of adipocytes with improved metabolic activity in Lcn2(-/-) mice, which may be associated with a more pronounced effect of Rosi treatment in reducing TGF-β in Lcn2(-/-) adipose tissue. Consistent with these in vivo observations, Lcn2 deficiency reduces the adipocyte differentiation capacity of stromal-vascular cells isolated from HFD-fed mice in these cells. Herein Rosi treatment was again able to stimulate adipocyte differentiation to a similar extent in WT and Lcn2(-/-) inguinal and epididymal stromal-vascular cells. Thus, combined, our data indicate that Lcn2 has a depot-specific role in HFD-induced adipose tissue remodeling.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23885013      PMCID: PMC3776868          DOI: 10.1210/en.2013-1289

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  44 in total

Review 1.  Adipose tissue remodeling and obesity.

Authors:  Kai Sun; Christine M Kusminski; Philipp E Scherer
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

Review 2.  Adipose tissue remodeling in pathophysiology of obesity.

Authors:  Mi-Jeong Lee; Yuanyuan Wu; Susan K Fried
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-07       Impact factor: 4.294

Review 3.  Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies.

Authors:  F Giorgino; L Laviola; J W Eriksson
Journal:  Acta Physiol Scand       Date:  2005-01

4.  Beneficial effects of subcutaneous fat transplantation on metabolism.

Authors:  Thien T Tran; Yuji Yamamoto; Stephane Gesta; C Ronald Kahn
Journal:  Cell Metab       Date:  2008-05       Impact factor: 27.287

5.  Lipocalin 2 deficiency alters estradiol production and estrogen receptor signaling in female mice.

Authors:  Hong Guo; Yuanyuan Zhang; David A Brockman; Wendy Hahn; David A Bernlohr; Xiaoli Chen
Journal:  Endocrinology       Date:  2012-01-10       Impact factor: 4.736

Review 6.  Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective.

Authors:  Sam Virtue; Antonio Vidal-Puig
Journal:  Biochim Biophys Acta       Date:  2010-01-06

Review 7.  Disordered lipid metabolism and the pathogenesis of insulin resistance.

Authors:  David B Savage; Kitt Falk Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

8.  Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis.

Authors:  T McLaughlin; A Sherman; P Tsao; O Gonzalez; G Yee; C Lamendola; G M Reaven; S W Cushman
Journal:  Diabetologia       Date:  2007-06-05       Impact factor: 10.122

9.  Adipocyte death, adipose tissue remodeling, and obesity complications.

Authors:  Katherine J Strissel; Zlatina Stancheva; Hideaki Miyoshi; James W Perfield; Jason DeFuria; Zoe Jick; Andrew S Greenberg; Martin S Obin
Journal:  Diabetes       Date:  2007-09-11       Impact factor: 9.461

10.  Intrinsic differences in adipocyte precursor cells from different white fat depots.

Authors:  Yazmín Macotela; Brice Emanuelli; Marcelo A Mori; Stephane Gesta; Tim J Schulz; Yu-Hua Tseng; C Ronald Kahn
Journal:  Diabetes       Date:  2012-05-17       Impact factor: 9.461

View more
  19 in total

Review 1.  Regulation of Energy Metabolism by Bone-Derived Hormones.

Authors:  Paula Mera; Mathieu Ferron; Ioanna Mosialou
Journal:  Cold Spring Harb Perspect Med       Date:  2018-06-01       Impact factor: 6.915

2.  Effect of lipopolysaccharides on adipogenic potential and premature senescence of adipocyte progenitors.

Authors:  Ming Zhao; Xiaoli Chen
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-06-23       Impact factor: 4.310

Review 3.  Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication.

Authors:  Jan-Bernd Funcke; Philipp E Scherer
Journal:  J Lipid Res       Date:  2019-06-17       Impact factor: 5.922

Review 4.  The role of osteoblasts in energy homeostasis.

Authors:  Naomi Dirckx; Megan C Moorer; Thomas L Clemens; Ryan C Riddle
Journal:  Nat Rev Endocrinol       Date:  2019-08-28       Impact factor: 43.330

5.  The induction of lipocalin-2 protein expression in vivo and in vitro.

Authors:  Peng Zhao; Carrie M Elks; Jacqueline M Stephens
Journal:  J Biol Chem       Date:  2014-01-05       Impact factor: 5.157

6.  Liver is the major source of elevated serum lipocalin-2 levels after bacterial infection or partial hepatectomy: a critical role for IL-6/STAT3.

Authors:  Ming-Jiang Xu; Dechun Feng; Hailong Wu; Hua Wang; Yvonne Chan; Jay Kolls; Niels Borregaard; Bo Porse; Thorsten Berger; Tak W Mak; Jack B Cowland; Xiaoni Kong; Bin Gao
Journal:  Hepatology       Date:  2015-02       Impact factor: 17.425

7.  Lipocalin 2 regulates brown fat activation via a nonadrenergic activation mechanism.

Authors:  Yuanyuan Zhang; Hong Guo; Jessica A Deis; Mara G Mashek; Ming Zhao; DonSanjiv Ariyakumar; Anibal G Armien; David A Bernlohr; Douglas G Mashek; Xiaoli Chen
Journal:  J Biol Chem       Date:  2014-06-10       Impact factor: 5.157

8.  The Detrimental Role Played by Lipocalin-2 in Alcoholic Fatty Liver in Mice.

Authors:  Yan Cai; Alvin Jogasuria; Huquan Yin; Ming-Jiang Xu; Xudong Hu; Jiayou Wang; Chunki Kim; Jiashin Wu; Kwangwon Lee; Bin Gao; Min You
Journal:  Am J Pathol       Date:  2016-07-15       Impact factor: 4.307

9.  Lipocalin 2, a Regulator of Retinoid Homeostasis and Retinoid-mediated Thermogenic Activation in Adipose Tissue.

Authors:  Hong Guo; Rocio Foncea; Sheila M O'Byrne; Hongfeng Jiang; Yuanyuan Zhang; Jessica A Deis; William S Blaner; David A Bernlohr; Xiaoli Chen
Journal:  J Biol Chem       Date:  2016-03-22       Impact factor: 5.157

10.  Lipocalin 2 expression and secretion is highly regulated by metabolic stress, cytokines, and nutrients in adipocytes.

Authors:  Yuanyuan Zhang; Rocio Foncea; Jessica A Deis; Hong Guo; David A Bernlohr; Xiaoli Chen
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.